IP Library Granted Patent US 9,682,071
Granted Patent B2
US 9,682,071 · App. 14/772,241 · Granted Jun 20, 2017

Methods of improving microvascular integrity

Inventors: Mark R. Nicolls (Palo Alto, CA); Karl Kossen (Brisbane, CA); Alan Cohen (Menlo Park, CA)
Assignees: INTERMUNE, INC.; THE BOARD OF TRUSTEES OF THE LELAND STANFORD
A61K31/4418A61K31/437A61K31/4412A61K31/4427A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,682,071
App. No.
14/772,241
Granted
Jun 20, 2017
Kind
B2
Abstract

The disclosure relates to methods of preserving or improving microvascular integrity in a patient in need thereof comprising administering pirfenidone therapy to the patient.

Claims (3)

1. A method for preserving or improving microvascular integrity or treating a microvascular disorder in a patient suffering from bronchiolitis obliterans, comprising administering pirfenidone to the patient, wherein the pirfenidone is administered to the patient prior to diagnosis/onset/showing signs or symptoms of fibrosis.

2. A method for preserving or improving microvascular integrity or treating a microvascular disorder in a patient suffering from bronchiolitis obliterans, comprising administering pirfenidone to the patient, wherein the pirfenidone is administered three times per day, with food.

3. A method for preserving or improving microvascular integrity or treating a microvascular disorder in a patient suffering from bronchiolitis obliterans, comprising administering pirfenidone to the patient, wherein the amount effective to preserve or improve microvascular integrity or treat the microvascular disorder is about 2400 or 2403 mg/day and wherein the pirfenidone is administered three times per day, with food.

Assignments (5)
SECURITY INTEREST Recorded Mar 23, 2026
From: LEGACY PHARMA INC. SEZC
To: ROOSTER LP
Reel/Frame 074151/0761 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2025
From: INTERMUNE, INC.
To: LEGACY PHARMA INC. SEZC
Reel/Frame 070877/0547 →
CERTIFICATE OF CHANGE OF COMPANY'S ADDRESS Recorded Jul 27, 2018
From: INTERMUNE, INC.
To: INTERMUNE, INC.
Reel/Frame 046638/0466 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2016
From: NICOLLS, MARK R.
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY; DEPARTMENT OF VETERANS AFFAIRS
Reel/Frame 037443/0042 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2016
From: COHEN, ALAN; KOSSEN, KARL
To: INTERMUNE, INC.
Reel/Frame 037443/0110 →
Continuity (2)
Provisional Application 61793035 · Mar 15, 2013
Related Publication 20160022654A1 · Jan 28, 2016